Log in

ETR:GXIGerresheimer Stock Price, Forecast & News

€61.00
-0.10 (-0.16 %)
(As of 04/5/2020 07:40 AM ET)
Add
Compare
Today's Range
€59.25
Now: €61.00
€61.80
50-Day Range
€53.00
MA: €63.26
€72.80
52-Week Range
€50.65
Now: €61.00
€74.80
Volume86,346 shs
Average Volume140,925 shs
Market Capitalization$1.92 billion
P/E Ratio23.71
Dividend Yield2.08%
BetaN/A
Gerresheimer AG manufactures and sells specialty glass and plastic products primarily for the pharma and healthcare industry worldwide. It operates through three divisions; Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The Plastics & Devices division offers drug delivery systems, including inhalers, pen systems, and injection systems; sterile and non-sterile prefillable syringe systems for the pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables and components for dialysis machines, and catheters and surgical devices. It also provides containers for the delivery of tablets and powders, liquid dosages, ophthalmic and rhinological applications, parenteral packaging applications, oral prescription medications, and cosmetics. The Primary Packaging Glass division offers glass primary packaging for medicines and cosmetics, such as ampoules, cartridges, vials, syrup and dropper bottles, tablet jars, and wide-neck jars, as well as injection, infusion, and transfusion bottles; flacons and pots for fragrances, deodorants, and care and decorative cosmetics; and bottles and jars for spirits and food. The Advanced Technologies division develops drug delivery products and platforms, such as micro pumps, which are used to self-administer medication for diabetes or Parkinson's for pharmaceutical and biotech customers. The company was founded in 1864 and is headquartered in Düsseldorf, Germany.
Read More
Gerresheimer logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.2Community Rank: 2.4Dividend Strength: 2.5Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.61 out of 5 stars


Industry, Sector and Symbol

Industry Medical Instruments & Supplies
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+49-211-618100

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.39 billion
Cash Flow€3.06 per share
Book Value€29.46 per share

Profitability

Miscellaneous

Employees9,867
Market Cap$1.92 billion
Next Earnings Date4/9/2020 (Estimated)
OptionableNot Optionable

Receive GXI News and Ratings via Email

Sign-up to receive the latest news and ratings for GXI and its competitors with MarketBeat's FREE daily newsletter.


Gerresheimer (ETR:GXI) Frequently Asked Questions

How has Gerresheimer's stock been impacted by COVID-19 (Coronavirus)?

Gerresheimer's stock was trading at €59.55 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, GXI shares have increased by 2.4% and is now trading at €61.00. View which stocks have been mosted impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Gerresheimer?

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Gerresheimer in the last year. There are currently 2 sell ratings, 3 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Gerresheimer.

When is Gerresheimer's next earnings date?

Gerresheimer is scheduled to release its next quarterly earnings announcement on Thursday, April 9th 2020. View our earnings forecast for Gerresheimer.

What price target have analysts set for GXI?

10 brokers have issued 1-year target prices for Gerresheimer's stock. Their forecasts range from €50.00 to €85.00. On average, they expect Gerresheimer's stock price to reach €72.57 in the next twelve months. This suggests a possible upside of 19.0% from the stock's current price. View analysts' price targets for Gerresheimer.

Has Gerresheimer been receiving favorable news coverage?

Media headlines about GXI stock have trended very negative this week, InfoTrie Sentiment Analysis reports. InfoTrie identifies negative and positive media coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Gerresheimer earned a media sentiment score of -3.3 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the stock's share price in the near term. View the latest news aboutGerresheimer.

Who are some of Gerresheimer's key competitors?

What other stocks do shareholders of Gerresheimer own?

Who are Gerresheimer's key executives?

Gerresheimer's management team includes the following people:
  • Mr. Dietmar Siemssen, CEO & Member of Management Board (Age 56)
  • Dr. Lukas Burkhardt, Member of Management Board (Age 40)
  • Ms. Katja Schnitzler, Group Director of Bus. Excellence & Continuous Improvement and Member of the Supervisory Board (Age 38)
  • Ms. Severine Camp, Corp. Sr. Director of Investor Relations
  • Mr. Jens Kürten, Group Sr. Director of Communication & Marketing and Press Officer of Corp. Media

What is Gerresheimer's stock symbol?

Gerresheimer trades on the ETR under the ticker symbol "GXI."

What is Gerresheimer's stock price today?

One share of GXI stock can currently be purchased for approximately €61.00.

How big of a company is Gerresheimer?

Gerresheimer has a market capitalization of $1.92 billion and generates $1.39 billion in revenue each year. Gerresheimer employs 9,867 workers across the globe. View additional information about Gerresheimer.

What is Gerresheimer's official website?

The official website for Gerresheimer is http://www.gerresheimer.com/.

How can I contact Gerresheimer?

Gerresheimer's mailing address is Klaus-Bungert-Strasse 4, DUESSELDORF, 40468, Germany. The company can be reached via phone at +49-211-618100.

This page was last updated on 4/5/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel